Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.59 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.59 |
| ▸ | CASP1 | P29466 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | S100A4 | P26447 | 4/20 | 0.52 |
| ▸ | PTPRC | P08575 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29354334 | 1.00 | BCL2 (0.60) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL12449237 | 1.00 | BCL2 (0.60) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL29356917 | 1.00 | BCL2 (0.60) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| Anthraquinone SCHEMBL4307959 | 1.00 | BCL2 (0.60) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL79475 | 1.00 | BCL2 (0.60) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL88058 | 1.00 | BCL2 (0.60) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| Bromide SCHEMBL28387245 | 0.98 | BCL2 (0.58) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL31500774 | 0.91 | DNMT1 (0.70) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL31500772 | 0.91 | DNMT1 (0.70) | BCL2CYP3A4DNMT1PABPC1CASP1 | |
| SCHEMBL43327 | 0.91 | DNMT1 (0.70) | BCL2CYP3A4DNMT1PABPC1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| WO-2011158211-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-12-22 | — | — | WO | disclosed |
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | PPOX, JUP, CRY2 | BCL2 3019/4885CYP3A4 1478/4885DNMT1 505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.